A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy (Q72686737)
Jump to navigation
Jump to search
scientific article published on 01 January 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy |
scientific article published on 01 January 1994 |
Statements
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy (English)
L T Goodnough
T H Price
K D Friedman
M Johnston
D Ciavarella
N Khan
R Sacher
W R Vogler
M Wissel